Neuberger Berman Group
EDIT icon

Neuberger Berman Group’s Editas Medicine EDIT Stock Holding History

Neuberger Berman Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,908
Closed -$22.4K – 2186
2025
Q4 		$22.4K Sell
10,908
-1,089
-9% -$3.14K ﹤0.01% 2088
2025
Q3 		$41.6K Sell
11,997
-1,710
-12% -$4.77K ﹤0.01% 2001
2025
Q2 		$30.2K Buy
+13,707
New +$22.4K ﹤0.01% 2005
2024
Q2 		– Sell
-275,069
Closed -$2.04M – 1919
2024
Q1 		$2.04M Buy
+275,069
New +$2.29M ﹤0.01% 1112
2021
Q1 		– Sell
-28,594
Closed -$2.02M – 1777
2020
Q4 		$2.02M Buy
+28,594
New +$1.17M ﹤0.01% 1108

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Neuberger Berman Group's EDIT Position: Q1 2026 in Review

Neuberger Berman Group sold out of Editas Medicine (EDIT) in Q1 2026, closing a stake of 10,908 shares — an estimated $22.4K sold.

Neuberger Berman Group first reported a position in EDIT in Q4 2020 and held it in 5 quarters. The position peaked at $2.04M in Q1 2024. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Neuberger Berman Group reported no remaining Editas Medicine position as of Q1 2026 after selling out during the quarter.
  • Neuberger Berman Group sold 10,908 Editas Medicine shares in Q1 2026, an estimated $22.4K.
  • Neuberger Berman Group first reported a position in Editas Medicine in Q4 2020 and held it in 5 quarters.
  • Neuberger Berman Group's Editas Medicine position peaked at $2.04M in Q1 2024.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.